The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1695
ISSUE1695
Med Lett Drugs Ther. 2024 Feb 5;66(1695):24 doi:10.58347/tml.2024.1695e
Disclosures
Objective(s)
In our article on Drugs for Depression, we should have included tardive dyskinesia (TD) in our list of adverse effects of second-generation antipsychotic (SGA) drugs. TD, which is more commonly associated with first-generation antipsychotics, can also occur in patients taking an SGA, especially with prolonged use. A meta-analysis found that the annualized incidence of TD was 2.6% in SGA users (M Carbon et al. World Psychiatry 2018; 17:330). Older adults are at increased risk.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.